Apostle MiniMax technology has been used and cited in this study:
- A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: phase 1 trial interim results. Amy R. Rappaport, Chrisann Kyi, Monica Lane, et al. Nature Medicine March 27, 2024
- Download PDF
